Dan McCall, CPA, MBA

Experience

• 

  PricewaterhouseCoopers

  Jun 1999 - Mar 2002

  Dual Track Senior Associate / Associate

  One of original two Dual Track employees hired by Big Four firm in the Northern Virginia/DC region. Through the Dual Track program, led both financial audits and general computer control reviews. • Planned and conducted audits of publicly traded clients with annual revenue in excess of $3 billion. Additional services included financial cycle reviews, regulatory reviews and general computer controls reviews.• Performed business process review at a government agency with an annual budget of over $55 billion. Was instrumental in securing follow-on work at the agency.• Supervised and trained staff and interns. • Selected to represent the firm and recruit students on multiple college campuses. Show less

• 

  Lafarge North America

  Mar 2002 - Aug 2003

  Financial Analyst

  Provided reporting, financial analysis and budgeting for the largest diversified construction materials company in the United States and Canada, with annual revenue in excess of $3 billion.• Created monthly financial reporting package, which included prior year and budget variance analysis of all product lines and regions. Results were reported in multiple currencies to the parent company in France.• Drafted multiple sections of the 10-K filing. Teamed with internal and external audit to ensure filing was submitted on time and in compliance with SEC regulations.• Controlled annual capital expenditure budget of $300 million. Led capital expenditure reporting and forecasting across all product lines.• Participated in the month-end closing call with 10 regional offices. Drafted analysis memo for executive team based on closing calls and analysis of financial statements.• Developed and implemented an Economic Value Added (EVA)model for product line and regional reporting. Show less

• 

  Liberty Property Trust

  Aug 2003 - Apr 2008

  Senior Financial Analyst / Financial Analyst

  Directed financial reporting, financial analysis, budgeting, and forecasting for one of the country’s largest publicly traded owners and managers of suburban commercial real estate, with a portfolio of over 700 properties and annual revenue of $700 million. In between August 2003 and April 2008, annual revenue increased $220 million (41%) through organic growth and the successful integration of domestic and international acquisitions and joint ventures. • Led the SEC reporting process for the company, which included 10-K, 10-Q and proxy filings. • Established, documented and maintained controls over various key processes identified as a result of the Sarbanes-Oxley Act.• Researched and ensured the proper GAAP accounting related to areas including revenue recognition, accounting for leases, joint ventures, share-based payments and the impairment or disposal of long-lived assets. • Prepared supplementary financial information packages used by analysts and investors to assess quarterly operating results. Attended the quarterly analyst call in support of the CFO.• Created and maintained forecast models supporting critical financial and company goals, including cash flow projections, earnings guidance and debt covenant monitoring. • Teamed with transfer agent to ensure proper count and accounting treatment for 90 million shares, options and units. Approved and processed stock option exercises in coordination with the legal and tax departments.• Utilized financial models to evaluate investment returns and capital structures of potential acquisitions and joint ventures. Performed due diligence for two potential acquisitions with over $500 million in revenue.• Streamlined and oversaw the company-wide budget process involving five regions and 20 cities, reducing the preparation time by one month. • Hired, trained and supervised finance department staff. Show less

• 

  Critical Homecare Solutions (acquired by BioScrip in March 2010)

  Apr 2008 - Mar 2010

  Director of Financial Reporting

  As a direct report to the CFO, led financial reporting, financial analysis, due diligence, budgeting and forecasting for a growing national leader in home care services and products, with 15,000 active patients and annual revenue of over $250 million. In between April 2008 and March 2010, annual revenue increased $60 million (31%) through organic growth and the successful integration of four acquisitions. • Directed financial reporting for the company, which included GAAP statements, board reports, bank reports, investor presentations and press releases. • Prepared financial data for SEC merger proxy filings, working with the executive team, personnel from the acquiring company, auditors, legal firms and investment bankers to complete critical areas of complex documents.• Coordinated due diligence and integration work for multiple acquisition targets with total revenue in excess of $75 million. Assessed risks and opportunities associated with targets, translating results into financial projections. The integrated acquisitions provided substantial 2009 EBITDA growth.• Streamlined monthly board reporting process, reducing workflow by 90% and the close process by two days.• Ensured financial statements were in accordance with GAAP and appropriate disclosures were included in the footnotes. Areas of focus included revenue recognition, fair value, business combinations, impairment of goodwill, share-based payments and preferred equity. • Designed model which enabled the company to forecast five years of cash flows, covenant ratios and other metrics. • Implemented cost-savings initiatives that resulted in a 9% reduction in vehicle leasing costs, 10% reduction in equipment leasing costs and 6% reduction in accounting research costs.• Managed time sensitive cross-functional projects related to payor contract renegotiation and contract analysis.• Hired and developed staff to ensure optimal results and improve bench strength. Show less

• 

  BioScrip

  Mar 2010 - Aug 2012

  Director of Financial Reporting

  Led financial reporting for a leading national provider of specialty pharmacy and home care products and services, with 125,000 active patients and annual revenue of over $1.7 billion. • Managed the external financial reporting process for the company in accordance with GAAP and SEC regulations, which included the 10-K, 10-Q, proxy, press releases and monthly bank reports.• Streamlined and prepared monthly financial reports used by the executive team to assess monthly operating results for over 110 locations in 29 states.• Ensured financial statements were in accordance with GAAP and appropriate disclosures were included in the footnotes. Areas of focus included revenue recognition, non-GAAP financial measures, fair value, business combinations, restructuring and segment reporting. • Oversaw the documentation and testing of internal controls over the financial reporting process in accordance with the Sarbanes-Oxley Act.• Acted as controller over legacy Critical Homecare Solutions operations during merger transition and integration.• Created and utilized model to analyze the allowance for doubtful accounts, allowance for contractual discounts and refunds payable reserve estimates.• Managed cross-functional revenue recognition and cutoff project which resulted in multiple changes to the company’s revenue recognition process.• Designed model which enabled the company to forecast monthly and yearly revenue based on daily deliveries and estimated revenue per delivery.• Provided background and overview of the finance function as part of the company’s presentation to the Accreditation Commission for Health Care panel. Show less

• 

  Endo Pharmaceuticals

  Aug 2012 - Jun 2016

  Director, Financial Reporting / Senior Manager, Financial Reporting

  Led the financial reporting team at a publicly traded pharmaceutical company comprised of over 100 legal entities with operations in over 15 countries and estimated 2016 revenue of $4.5 billion. In between August 2012 and May 2016, the company consummated ten acquisitions for over $14.0 billion; divested of two operating segments; executed a corporate inversion to Ireland; completed $18.0 billion in debt, preferred stock and equity issuances; accounted for a product liability settlement of almost $3.0 billion and implemented four restructuring plans. • Led a complex, global financial reporting process which included periodic reporting for the consolidated company on the United States (SEC), Canadian (SEDAR) and Irish (GEM) exchange markets, consolidated subsidiary bank financial statements, guarantor financial statements and foreign subsidiary statutory filings.• Provided financial reporting for seven debt offerings raising $9.9 billion, three equity offerings to finance acquisitions raising $5.7 billion, one public equity offering raising $2.3 billion and a preferred stock issuance of $60 million.• Led presentations on a quarterly basis to the executive leadership team covering the financial statements and related footnote disclosures and significant accounting issues.• Prepared presentations and support for board meetings and analyst calls.• Streamlined multiple processes into consolidated model which produced various sets of financial statements, variance analyses, intercompany analysis, cash flow reports and working capital analysis.• Served as finance lead on multiple S-4 preparation and filing processes, which included coordination of the drafting process and day-to-day interaction and collaboration with the banks, printers, and outside counsel.• Participated in purchase accounting for ten acquisitions, integrating each into the financial reporting process, including the consolidation of multiple ERP systems and foreign currencies. Show less

• 

  Affiliated Distributors (AD)

  Oct 2016 - now

  • Vice President and Corporate Contro

    Jan 2021 - now

  • Senior Director of Accounting

    Jan 2018 - Jan 2021

  • Director of Accounting

    Oct 2016 - Jan 2018